Binding of peptides to HLA-DQ molecules: Peptide binding properties of the disease-associated HLA-DQ(α10501, β10201) molecule

International Immunology

Volumn 6, Issue 3, 1994, Pages 453-461

  Johansen, Bente H ^a   Buus, Søren ^a,b   Vartda, Frode ^d   Vlken, Helge ^d   Eriksen, Jon A ^a,c   Thorsby, Erik ^d   Sollid, Ludvlg M ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STATOIL   (Norway)

^d NONE

Author keywords

Celiac disease; DQ; DQ2; HLA; Peptide binding

Indexed keywords

BIOLOGICAL MARKER; HLA DQ ANTIGEN; HLA DR3 ANTIGEN; IA ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY AFFINITY; ARTICLE; BINDING KINETICS; BIOASSAY; CELIAC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL NOISE RATIO;

AMINO ACID SEQUENCE; BINDING, COMPETITIVE; CELL LINE, TRANSFORMED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HLA-DQ ANTIGENS; HUMAN; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; SUPPORT, NON-U.S. GOV'T; TEMPERATURE;

EID: 0028329025     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/6.3.453     Document Type: Article

References (31)

1. Sotlkd, L. M., Markussen, G., Ek, J., Gjerde, H., Vartdal, F., and Thorsby, E. 1989. Evidence for a primary association of celiac disease to a particular HLA-DQ alfi heterodimer. J. Exp. Med. 169:345.
2. Todd, J. A., Bell, J. I., and McDevitt, H. 0. 1987. HLA-DQ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599.
3. Thorsby, E. and Flpnnirtgen, K. S. 1993. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus. Diabetotogia 36:371.
4. Buus, S., Sette, A., Coldn, S. M., Jenis, D. M., and Grey, H. 1986. Isolation and characterization of antigen -la complexes involved in T cell recognition. Cell 47:1071.
5. O’Sullivan, D., Sidney, J., Appella, E., Walker, L., Phillips, L., Coldn, S. M., Miles, C., Chesnut, R. W., and Sette, A. 1990. Characterization of the specificity of peptide binding to four DR haptotypes. J. Immunol. 145:1799.
6. Gorga, J. C., Horejisi, V., Johnson, D. R., Raghupathy, R., and Strominger, J. L. 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. Biol. Chem. 262:16087.
7. Schneider, C., Newman, R. A., Sutherland, D. R., Ushi, A., and Greaves, M F. 1982. A one-step purification of membrane proteins using a high efficiency immunomatrix. J. Biol. Chem. 257:10766.
8. Lampson, L. A. and Levy, R. 1980. Two populations of la-like molecules on a human B cell line. J. Immunol. 125:293.
9. Rebai, N., Malissen, B., Pierres, M., Accolla, R. S., Code, G., and Mawas, C. 1983. Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-lak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb. Eur. J. Immunol. 13:106.
10. Greenwood, F. C., Hunter, W. H., and Glover, J. S. 1963. The preparation of131 l-labelled human growth hormone of high specific radioactivity. Biochem. J. 89:114.
11. Mouritsen, S., Hansen, A. S., Petersen, B. L., and Buus, S. 1992. pH-dependence of the interaction between immunogenic peptide and MHC class II molecules. J. Immunol. 148:1438.
12. Sidney, J., Oseroff, C., Southwood, S., Wall, M., Ishioka, G., Koning, F., and Sette, A. 1992. DRB1 ‘0301 molecules recognize a structural motif distinct from the one recognized by most DR/3, alleles. J. Immunol. 149:2634.
13. Kwok, W. W., Schwarz, D., Nepom, B. S., Hock, R. A., Thurtle, P. S., and Nepom, G. T. 1988. HLA-DQ molecules form a -f heterodimers of mixed allotype. J. Immunol. 141:3123.
14. Spits, H., Ijssel, H., Thompson, A., and de Vries, J. E. 1983. Human T4+ and T8+ cytotoxic T lymphoctye clones directed at products of different dass II major histocompatibility complex loci. J. Immunol. 131:678.
15. Fermand, J.-P., Chevalier, A., and Brouet, J.-C. 1986. Characterization of a monoclonal antibody recognizing a monomorphic determinant of the alpha chain of class II DQ antigens. Scand. J. Immunol. 24:313.
16. Amar, A., Radka, S. F., Holbeck, S. L., Kim, S. J., Nepom, B. S., Nelson, K., and Nepom, G. T. 1987. Characterization of specific HLA-DQa allospedfidties by genomic, biochemical, and serological analysis. J. Immunol. 138:3986.
17. Dayan, C. M., Londei, M., Corcoran, A E., Grubeck-Loebenstein, B., James, R. F. L., Rapoport, B., and Feldmann, M. 1991. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc. Nad Acad. Scr. USA 88:7415.
18. Kimura, S., Kotani, T., McBride, O. W., Umeki, K., Hirai, K., Nakayama, T., and Ohtaki, S. 1987. Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternatively spliced mRNAs Proc. Natl Acad. Sci. USA 84:5555.
19. Celis, E, Karr, R W, Dietzschold, B., Wunrver, W. H., and Koprowski, H. 1988. Genetic restriction and fine specificity of human T cell clones reactive with rabies virus. J. Immunol 141 2721.
20. Cells, E., Karr, R. W., Gregersen, P. K., and Reinsmoen, N. L. 1990. Functional analysis of MHC class ll-restricted T cells derived from a Caucasian with a DR4, Dw15, DQw8 haplotype. Hum. Immunol. 29-31.
21. Quayle, A. J, Wilson, K B, Li, S. G, Kjeldsen-Kragh, J, Oftung, F., Shinruck, T, Soud, M, Fprre, O, Capra, J D, and Natvig, J. B. 1992. Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T clones from rheumatotd synovial fluid. Eur. J. Immunol. 22.1315.
22. Guttinger, M., Romagnoli, P., Vandel, L., Metoen, R., Takacs, B, Pink, J. R. L, and Sinigaglia, F. 1991. HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate. Int. Immunol. 3 899.
23. Sette, A., Southwood, S., O’Sullivan, D., Gaeta, F C. A., Sidney, J, and Grey, H. 1992. Effect of pH on MHC cfass ll-peptide interacton. J. Immunol. 148:844.
24. Roche, P. A. and Cresswell, P. 1990. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J. Immunol. 144 1 849
25. Jardetzky, T. S., Gorga, J. C., Busch, R., Rothbard, J., Strominger, J. L., and Wiley, D. C. 1990. Peptide binding to HLA-DR1: A peptde with most residues substituted to alanine retains MHC binding. EMBO J. 9:1797.
26. Geluk, A, Bloemhoff, W., De Vries, R. R. P., and Ottenhoff, T. H. M. 1992. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules. Eur. J. Immunol. 22:107.
27. Bjorkman, P J., Saper, M. A., Samraoui, B., Bennet, W. S., Strominger, J. L., and Wley, D. C. 1987. The foreign antgen binding site and T cell recognition regions of class I histocompatibaity antigens. Nature 329:512.
28. Brown, J. H., Jardetzky, T S., Gorga, J. C., Stern, L. J., Urban R. G., Strominger, J. L., and Wley, D. C. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
29. Billing, R. J., Safani, M., and Peterson, P. 1976. Isolation and characterization of human Bcell alloantigens. J. Immunol. 117:1589.
30. Dornmair, K., RothenhSusler, B., and McConnell, H M. 1989. Structure intermediates in the reactions of antigenic peptides with MHC molecules Cold Spring Harbor Symp. Quant. Biol. 54:409.
31. Stern, L. J and Wley, D. C. 1992. The human class II MHC protein HLA-DR1 assembles as empty a(3 heterodimers in the absence of antigenic peptides. Cell 68.465.